Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIST2 intrapleural DNase and alteplase in pleural infection
2004-000658-22Phase 2Completed
- Sponsor
- University of Oxford
- Start
- May 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dornase alfa and tissue-plasminogen activator in empyema, parapneumonic effusion and pleural abscess (4 arms), sponsored by University of Oxford. Primary endpoint: Radiographic improvement in pleural collection area. Started May 2005; status: completed.
02
Drugs
dornase alfatissue-plasminogen activator
03
Conditions
empyemaparapneumonic effusionpleural abscess
Beyond the preview
Go deeper on 2004-000658-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000658-22.